palbociclib
Palbociclib is a drug used to treat Breast Cancer, Breast Neoplasms, HER2/Neu Negative, and other conditions. Palbociclib is being actively studied in 131 studies and prior, has been studied in 31.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
Pfizer | Dana-Farber Cancer Institute | Geoffrey Shapiro, MD, PhD |
Dana-Farber Cancer Institute | Washington University School of Medicine | Erica Mayer, MD, MPH |
National Cancer Institute (NCI) | Beth Israel Deaconess Medical Center | Yeon Hee Park |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Not yet recruiting
- Breast Cancer
- Head and Neck Cancer
- Palbociclib
- +3 more
- (no location specified)
2022-01-26
Jan 26, 2022S
Active, not recruiting
- Metastatic Breast Cancer
- Fulvestrant
- +2 more
- Pittsburgh, PennsylvaniaMagee-Womens Hospital UPMC
2021-07-22
Jul 22, 2021W
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Palbociclib
- +5 more
- Saint Louis, MissouriWashington University School of Medicine
2022-02-25
Feb 25, 2022P
Completed
- Metastatic Breast Cancer
- palbociclib
- Herzliya Pituach, IsraelPfizer Pharmaceuticals Israel Ltd.
2022-01-20
Jan 20, 2022S
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- Fulvestrant
- Washington, District of Columbia
- +4 more
2022-01-10
Jan 10, 2022F
Active, not recruiting
- Metastatic Breast Cancer
- Palbociclib
- Shanghai, ChinaFudan University Shanghai Cancer Center
2021-09-13
Sep 13, 2021F
Recruiting
- Estrogen Receptor-positive Breast Cancer
- HER2-positive Breast Cancer
- Palbociclib
- +3 more
- Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Hospital
2021-09-29
Sep 29, 2021A
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- Timisoara, Timiș, RomaniaAsociatia Oncohelp - Centrul de Oncologie Oncohelp
2022-02-15
Feb 15, 2022M
M
Recruiting
- Metastatic Malignant Neoplasm to Brain
- Palbociclib
- Boston, Massachusetts
- +1 more
2021-10-25
Oct 25, 2021B
Not yet recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- Axitinib
- +2 more
- Boston, Massachusetts
- +2 more
2021-12-16
Dec 16, 2021N
Active, not recruiting
- Advanced Lymphoma
- +4 more
- Palbociclib
- Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
2022-02-04
Feb 4, 2022U
Recruiting
- Cancer of the Colon
- +4 more
- Cetuximab
- Palbociclib
- Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
2022-01-25
Jan 25, 2022R
Recruiting
- Colorectal Carcinoma
- +3 more
- Binimetinib
- +2 more
- Buffalo, New YorkRoswell Park Cancer Institute
2021-12-30
Dec 30, 2021A
Recruiting
- Metastatic Breast Cancer
- +4 more
- Palbociclib
- +2 more
- Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
2021-07-20
Jul 20, 2021A
Recruiting
- Female Breast Carcinoma
- anastrozole
- Palbociclib
- Charlotte, North CarolinaLevine Cancer Institute
2022-02-21
Feb 21, 2022D
Active, not recruiting
- KRAS Mutant Non-Small Cell Lung Cancer
- Solid Tumors
- Palbociclib
- PD-0325901
- Boston, MassachusettsDana Farber Cancer Institute
2022-01-18
Jan 18, 2022U
Active, not recruiting
- Breast Cancer
- Palbociclib
- +2 more
- Groningen, NetherlandsUniversity Medical Center Groningen
2021-02-01
Feb 1, 2021S
Recruiting
- Recurrent B Acute Lymphoblastic Leukemia
- Refractory B Acute Lymphoblastic Leukemia
- Palbociclib
- Dexamethasone
- Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-07
Apr 7, 2022T
Recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- +2 more
- Palbociclib
- +3 more
- Stanford, CaliforniaLucile Packard Children's Hospital Stanford
2021-09-20
Sep 20, 2021D
Active, not recruiting
- Ewing Sarcoma
- Ewing's Sarcoma Recurrent
- Palbociclib
- Ganitumab
- Boston, Massachusetts
- +2 more
2022-03-21
Mar 21, 2022H
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- +2 more
- Johannesburg, South AfricaWits Oncology center
2021-07-22
Jul 22, 2021D
A
Recruiting
- Breast Cancer
- HCQ
- +2 more
- Philadelphia, PennsylvaniaUniversity of Pennsylvania
2021-07-26
Jul 26, 2021J
Active, not recruiting
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
- Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
2021-10-07
Oct 7, 2021